House Republicans voted to ban quality-adjusted life years (QALYs) from being used as a drug pricing metric in federal health programs; insurance executives disapproved of newly proposed 2025 Medicare Advantage (MA) rates; patients with long COVID enrolled in an online exercise program said their health improved more than people who received standard care.
Read More
Study Finds Significant Hair Regrowth in Patients With Patchy AA Following Baricitinib Treatment
February 7th 2024Baricitinib was found to be an effective treatment for patchy alopecia areata (AA), in a retrospective study, with most patients experiencing hair regrowth after 4 to 16 weeks of treatment.
Read More
High Rates of "Deaths of Despair" Observed Among White Americans
February 7th 2024While White individuals are less likely to suffer from severe psychological distress, findings showed White individuals are more likely to experience “deaths of despair” when compared with Black and Hispanic individuals in the US.
Read More
Possible Increase in Prevalence of Alzheimer Disease Found in Patients With Myasthenia Gravis
February 6th 2024Investigators observed an increase in the prevalence of Alzheimer disease in patients with diagnosed myasthenia gravis (MG), which indicates that MG is an independent risk factor for AD.
Read More
Ever-Smokers With COPD Have a Greater Risk of Developing ADHD, Study Says
February 6th 2024No causal association with psychiatric disorders was observed in patients with chronic obstructive pulmonary disease (COPD) without a smoking history, while ever-smokers with COPD had a greater risk of developing attention-deficit/hyperactivity disorder (ADHD).
Read More
Study Highlights Relationship Between Alcohol Use, Socioeconomic Status, and IHD Mortality Risk
February 6th 2024Light-to-moderate alcohol consumption seemed to provide greater protection against ischemic heart disease (IHD) mortality for individuals with higher socioeconomic status (SES) compared with those with lower SES, likely due to gaps in access to necessary care.
Read More
Targeted Therapy Associated With Lower SPM Risk Among Treated Patients With CLL
February 6th 2024Investigators found patients receiving chemotherapy had a greater risk of a secondary primary malignancy (SPM) compared with those treated with targeted therapies or those whose chronic lymphocytic leukemia (CLL) was left untreated.
Read More
Medicare Value-Based Purchasing Program Yields Comparable 30-Day Mortality Rates Across Hospitals
February 5th 2024Although 30-day mortality rates did not worsen for Medicare beneficiaries at hospitals with high proportions of Black patients compared with other hospitals, gaps in outcomes widened for Black adults with pneumonia under the Medicare Value-Based Purchasing Program.
Read More
Pre-, Postinfusion Protocol Recommendations for Delandistrogene Moxeparvovec Use in DMD
February 5th 2024The gene therapy delandistrogene moxeparvovec-rokl, also known as Elevidys (Sarepta Therapeutics) is indicated to treat Duchenne muscular dystrophy (DMD) in ambulatory patients aged 4 to 5 years, and Sarepta recently filed supplemental data with the FDA seeking to expand the labeled indication.
Read More
Permanent Pacemaker Implantation Frequently Follows Tricuspid Valve Surgery, Study Finds
February 5th 2024Among Medicare beneficiaries, implantation was especially frequent for female patients and those undergoing tricuspid valve replacement with or without concomitant left-sided heart surgeries.
Read More